Looking for scholarly content to start your research? Search EBSCOhost

Newsletter Archives

Showing 221 to 240 of 869 articles.

MBE em foco - Volume 7 Issue 5

Injetando alguma esperança com a vacina da COVID-19

EBM Focus - Volume 16, Issue 17

Benefits of bringing the hospital home

EBM Focus - Volume 16, Issue 16

Injecting some hope with the COVID-19 vaccine

EBM Focus - Volume 16, Issue 15

CAPping treatment at 3 days for pneumonia

EBM Focus - Volume 16, Issue 14

This analysis of prn fluticasone might be a little stuffy

MBE em foco - Volume 7, Issue 4

Voltando ao velho ritmo na fibrilação atrial?

EBM Focus - Volume 16, Issue 13

For valvular atrial fibrillation, DOACs may do it better

EBM Focus - Volume 16, Issue 12

Question everything, including the placebo effect

EBM Focus - Volume 16, Issue 11

Two steps to the ’best’ test for gestational diabetes

MBE em foco - Volume 7, Issue 3

Notícias quentes: calor e poluição do ar estão associados a desfechos gestacionais desfavoráveis

EBM Focus - Volume 16, Issue 10

Antibiotic treatment could be CAPped at 5 days in kids

EBM Focus - Volume 16, Issue 9

NPH vs. long-acting insulins: What’s the real cost?

EBM Focus - Volume 16, Issue 8

Stratifying patients with TIAs: Who needs hospitalization?

EBM Focus - Volume 16, Issue 7

$emaglutide for weight loss leads to looser belts and lighter purses

MBE em foco - Volume 7 Issue 2

Atualização sobre o tocilizumabe para a COVID-19

EBM Focus - Volume 16, Issue 6

EAGeR to find significance, researchers use new [per] protocol to reanalyze preconception aspirin data

EBM Focus - Volume 16, Issue 5

MIS-Cing methylprednisolone in the management of multisystem inflammatory syndrome in children with COVID?

EBM Focus - Volume 16, Issue 4

Modified research protocol breaks our heart a little in an otherwise handsome trial of sotagliflozin (SOLOIST-WHF)

EBM Focus - Volume 16, Issue 3

Increasing pressure to stop PRN treatment of elevated SBP in hospitalized patients

MBE em foco - Volume 7, Issue 1

Azitromicina e propensão para morte: efeito colateral ou pacientes mais doentes?